These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 18931010

  • 1. Cerebrospinal fluid anti-myelin antibodies are related to magnetic resonance measures of disease activity in multiple sclerosis.
    Vogt MH, Teunissen CE, Iacobaeus E, Heijnen DA, Breij EC, Olsson T, Brundin L, Killestein J, Dijkstra CD.
    J Neurol Neurosurg Psychiatry; 2009 Oct; 80(10):1110-5. PubMed ID: 18931010
    [Abstract] [Full Text] [Related]

  • 2. Cerebrospinal fluid anti-whole myelin antibodies are not correlated to magnetic resonance imaging activity in multiple sclerosis.
    Tewarie P, Teunissen CE, Dijkstra CD, Heijnen DA, Vogt M, Balk L, Vrenken H, Polman CH, Killestein J.
    J Neuroimmunol; 2012 Oct 15; 251(1-2):103-6. PubMed ID: 22858371
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association.
    Mantegazza R, Cristaldini P, Bernasconi P, Baggi F, Pedotti R, Piccini I, Mascoli N, La Mantia L, Antozzi C, Simoncini O, Cornelio F, Milanese C.
    Int Immunol; 2004 Apr 15; 16(4):559-65. PubMed ID: 15039386
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Multiple sclerosis: Neurofilament light chain antibodies are correlated to cerebral atrophy.
    Eikelenboom MJ, Petzold A, Lazeron RH, Silber E, Sharief M, Thompson EJ, Barkhof F, Giovannoni G, Polman CH, Uitdehaag BM.
    Neurology; 2003 Jan 28; 60(2):219-23. PubMed ID: 12552034
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases.
    Di Pauli F, Mader S, Rostasy K, Schanda K, Bajer-Kornek B, Ehling R, Deisenhammer F, Reindl M, Berger T.
    Clin Immunol; 2011 Mar 28; 138(3):247-54. PubMed ID: 21169067
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Novel cerebrospinal fluid and serum autoantibody targets for clinically isolated syndrome.
    Rouwette M, Somers K, Govarts C, De Deyn PP, Hupperts R, Van Wijmeersch B, De Jong BA, Verbeek MM, Van Pesch V, Sindic C, Villar LM, Álvarez-Cermeño JC, Stinissen P, Somers V.
    J Neurochem; 2012 Nov 28; 123(4):568-77. PubMed ID: 22958230
    [Abstract] [Full Text] [Related]

  • 12. Elevated antibody reactivity to measles virus NCORE protein among patients with multiple sclerosis and their healthy siblings with intrathecal oligoclonal immunoglobulin G production.
    Persson L, Longhi S, Enarsson J, Andersen O, Haghigi S, Nilsson S, Lagging M, Johansson M, Bergström T.
    J Clin Virol; 2014 Sep 28; 61(1):107-12. PubMed ID: 25022622
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antibodies to the axolemma-enriched fraction in the cerebrospinal fluid and serum of patients with multiple sclerosis and other neurological diseases.
    Rawes JA, Calabrese VP, Khan OA, DeVries GH.
    Mult Scler; 1997 Dec 28; 3(6):363-9. PubMed ID: 9493635
    [Abstract] [Full Text] [Related]

  • 16. Anti-glycolipid antibodies and their immune complexes in multiple sclerosis.
    Kasai N, Pachner AR, Yu RK.
    J Neurol Sci; 1986 Aug 28; 75(1):33-42. PubMed ID: 2427659
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antibodies to sulfatide in cerebrospinal fluid of patients with multiple sclerosis.
    Ilyas AA, Chen ZW, Cook SD.
    J Neuroimmunol; 2003 Jun 28; 139(1-2):76-80. PubMed ID: 12799023
    [Abstract] [Full Text] [Related]

  • 20. Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysis.
    Jarius S, König FB, Metz I, Ruprecht K, Paul F, Brück W, Wildemann B.
    J Neuroinflammation; 2017 Aug 29; 14(1):171. PubMed ID: 28851393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.